163 related articles for article (PubMed ID: 19713062)
1. [Peripheral arterial disease with lower limb claudication: Medical treatment].
Long A; Bui HT; Journet J; Hadj Henni A
J Mal Vasc; 2009 Nov; 34(5):323-9. PubMed ID: 19713062
[TBL] [Abstract][Full Text] [Related]
2. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
3. Medical management of peripheral arterial disease.
Creager MA
Cardiol Rev; 2001; 9(4):238-45. PubMed ID: 11405904
[TBL] [Abstract][Full Text] [Related]
4. Medical treatment of peripheral arterial disease.
Hankey GJ; Norman PE; Eikelboom JW
JAMA; 2006 Feb; 295(5):547-53. PubMed ID: 16449620
[TBL] [Abstract][Full Text] [Related]
5. Clinical manifestation of atherosclerotic peripheral arterial disease and the role of cilostazol in treatment of intermittent claudication.
Grouse JR; Allan MC; Elam MB
J Clin Pharmacol; 2002 Dec; 42(12):1291-8. PubMed ID: 12463722
[TBL] [Abstract][Full Text] [Related]
6. Peripheral arterial disease.
Hiatt WR; Nehler MR
Adv Intern Med; 2001; 47():89-110. PubMed ID: 11795081
[No Abstract] [Full Text] [Related]
7. Office management of peripheral arterial disease.
Aronow WS
Am J Med; 2010 Sep; 123(9):790-2. PubMed ID: 20800143
[TBL] [Abstract][Full Text] [Related]
8. Medical and lifestyle management of peripheral arterial disease.
Parvar SL; Fitridge R; Dawson J; Nicholls SJ
J Vasc Surg; 2018 Nov; 68(5):1595-1606. PubMed ID: 30360849
[TBL] [Abstract][Full Text] [Related]
9. [Peripheral arterial disease: Treatment].
Desormais I; Aboyans V; Pesteil F; Lacroix P
Presse Med; 2018 Jan; 47(1):56-61. PubMed ID: 29273182
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic therapy for peripheral arterial disease and claudication.
Hiatt WR
J Vasc Surg; 2002 Dec; 36(6):1283-91. PubMed ID: 12469066
[TBL] [Abstract][Full Text] [Related]
11. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
[TBL] [Abstract][Full Text] [Related]
12. Current and future drug therapies for claudication.
Hiatt WR
Vasc Med; 1997; 2(3):257-62. PubMed ID: 9546977
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.
Khan S; Flather M; Mister R; Delahunty N; Fowkes G; Bradbury A; Stansby G
Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):442-50. PubMed ID: 17196851
[TBL] [Abstract][Full Text] [Related]
14. The role of cilostazol (Pletal) in the management of intermittent claudication.
Bradbury AW
Int J Clin Pract; 2003 Jun; 57(5):405-9. PubMed ID: 12846346
[TBL] [Abstract][Full Text] [Related]
15. Management of peripheral arterial disease and intermittent claudication.
Schainfeld RM
J Am Board Fam Pract; 2001; 14(6):443-50. PubMed ID: 11757887
[TBL] [Abstract][Full Text] [Related]
16. [Secondary prevention and conservative therapy of obliterative arteriosclerosis].
Landi A
Orv Hetil; 2004 May; 145(20):1035-43. PubMed ID: 15202325
[TBL] [Abstract][Full Text] [Related]
17. Drug treatment of peripheral arterial disease in the elderly.
Aronow WS
Drugs Aging; 2006; 23(1):1-12. PubMed ID: 16492065
[TBL] [Abstract][Full Text] [Related]
18. Current medical therapies for patients with peripheral arterial disease: a critical review.
Regensteiner JG; Hiatt WR
Am J Med; 2002 Jan; 112(1):49-57. PubMed ID: 11812407
[TBL] [Abstract][Full Text] [Related]
19. [Medical treatment of arteriosclerosis obliterans (ASO)].
Matsuo H
Nihon Geka Gakkai Zasshi; 1996 Jul; 97(7):520-5. PubMed ID: 8808815
[TBL] [Abstract][Full Text] [Related]
20. Peripheral arterial disease.
Cassar K; Bachoo P
Clin Evid; 2006 Jun; (15):164-76. PubMed ID: 16973009
[No Abstract] [Full Text] [Related]
[Next] [New Search]
